Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The spermatogonial stem cell (SSC) and testicular niche represent the specialized microenvironment within the seminiferous tubules of the testis that supports the maintenance, self-renewal, and differentiation of male germline stem cells (NIH, 2023). This niche is composed of various somatic cell types, including Sertoli cells, Leydig cells, and peritubular myoid cells, which provide essential physical support and paracrine signaling factors such as glial cell line-derived neurotrophic factor (GDNF) and fibroblast growth factor 2 (FGF2) (Di Persio et al., 2022). The precise regulation of this environment is critical for continuous sperm production throughout a male's life and for the restoration of fertility following injury (Sharma et al., 2019). Disruptions to the SSC niche, often caused by gonadotoxic treatments like chemotherapy (e.g., busulfan) or environmental toxins, can lead to permanent infertility or the development of testicular germ cell tumors (NIH, 2008). While not a single molecular target, the niche is a focal point for regenerative medicine and fertility preservation strategies, where drugs and growth factors are used to manipulate stem cell behavior or protect the germline from damage (Sohni et al., 2019). Understanding the molecular crosstalk within this niche is essential for developing therapies for non-obstructive azoospermia and other forms of male factor infertility (Di Persio et al., 2022).
Regulation of stem cell fate through paracrine signaling and physical interactions with somatic cells to maintain the balance between self-renewal and differentiation.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Spermatogonial stem cells and testicular niche (SSC niche).